Biorestorative Therapies Stock Analysis
| BRTX Stock | USD 1.92 0.05 2.54% |
BioRestorative Therapies is fairly valued with Real Value of 1.94 and Target Price of 13.0. The main objective of BioRestorative Therapies stock analysis is to determine its intrinsic value, which is an estimate of what BioRestorative Therapies is worth, separate from its market price. There are two main types of BioRestorative Therapies' stock analysis: fundamental analysis and technical analysis.
The BioRestorative Therapies stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. BioRestorative Therapies is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. BioRestorative Stock trading window is adjusted to America/New York timezone.
BioRestorative |
BioRestorative Stock Analysis Notes
About 28.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.37. Some equities with similar Price to Book (P/B) outperform the market in the long run. BioRestorative Therapies recorded a loss per share of 2.38. The entity had not issued any dividends in recent years. The firm had 1:4000 split on the 27th of October 2021. BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. BioRestorative Therapies, Inc. was incorporated in 1997 and is based in Melville, New York. Biorestorative Therapies operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 7 people. For more info on BioRestorative Therapies please contact the company at 631 760 8100 or go to https://www.biorestorative.com.BioRestorative Therapies Quarterly Total Revenue |
|
BioRestorative Therapies Investment Alerts
| BioRestorative Therapies is way too risky over 90 days horizon | |
| BioRestorative Therapies may become a speculative penny stock | |
| BioRestorative Therapies appears to be risky and price may revert if volatility continues | |
| BioRestorative Therapies has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 145.8 K. Net Loss for the year was (10.42 M) with profit before overhead, payroll, taxes, and interest of 352.27 K. | |
| BioRestorative Therapies currently holds about 17.93 M in cash with (6.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.92, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 28.0% of the company shares are held by company insiders | |
| Latest headline from zacks.com: Stoke Therapeutics, Inc. Reports Q4 Loss, Tops Revenue Estimates |
BioRestorative Therapies Upcoming and Recent Events
Earnings reports are used by BioRestorative Therapies to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
BioRestorative Largest EPS Surprises
Earnings surprises can significantly impact BioRestorative Therapies' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-13 | 2024-06-30 | -0.56 | -0.5 | 0.06 | 10 | ||
2024-03-18 | 2023-12-31 | -0.69 | -0.57 | 0.12 | 17 | ||
2022-11-14 | 2022-09-30 | -1.45 | -1.28 | 0.17 | 11 |
BioRestorative Stock Institutional Investors
| Shares | Advisor Group Holdings, Inc. | 2024-12-31 | 193 | Sbi Securities Co Ltd | 2024-12-31 | 60.0 | Bank Of America Corp | 2024-12-31 | 42.0 | Td Waterhouse Canada Inc | 2024-12-31 | 2.0 | Susquehanna International Group, Llp | 2024-12-31 | 0.0 | Wells Fargo & Co | 2024-09-30 | 0.0 | Renaissance Technologies Corp | 2024-12-31 | 0.0 | Geode Capital Management, Llc | 2024-12-31 | 54.7 K | Stonex Group Inc | 2024-12-31 | 50.1 K | Wealth Alliance, Llc | 2024-12-31 | 40 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 27.5 K |
BioRestorative Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.29 M.BioRestorative Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.79) | (0.83) | |
| Return On Capital Employed | (1.75) | (1.66) | |
| Return On Assets | (0.74) | (0.78) | |
| Return On Equity | (1.20) | (1.14) |
Management Efficiency
BioRestorative Therapies has return on total asset (ROA) of (0.5324) % which means that it has lost $0.5324 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8456) %, meaning that it created substantial loss on money invested by shareholders. BioRestorative Therapies' management efficiency ratios could be used to measure how well BioRestorative Therapies manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.83 in 2025. Return On Capital Employed is likely to rise to -1.66 in 2025. At this time, BioRestorative Therapies' Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 368.6 K in 2025, whereas Non Current Assets Total are likely to drop slightly above 1.3 M in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.13 | 2.24 | |
| Tangible Book Value Per Share | 1.98 | 2.08 | |
| Enterprise Value Over EBITDA | (0.40) | (0.42) | |
| Price Book Value Ratio | 0.66 | 0.69 | |
| Enterprise Value Multiple | (0.40) | (0.42) | |
| Price Fair Value | 0.66 | 0.69 | |
| Enterprise Value | 7.6 M | 4.5 M |
Understanding the operational decisions made by BioRestorative Therapies management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Technical Drivers
As of the 26th of March, BioRestorative Therapies shows the Mean Deviation of 4.7, risk adjusted performance of 0.0781, and Downside Deviation of 6.06. BioRestorative Therapies technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.BioRestorative Therapies Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. BioRestorative Therapies middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for BioRestorative Therapies. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
BioRestorative Therapies Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BioRestorative Therapies insiders, such as employees or executives, is commonly permitted as long as it does not rely on BioRestorative Therapies' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases BioRestorative Therapies insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
BioRestorative Therapies Outstanding Bonds
BioRestorative Therapies issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BioRestorative Therapies uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BioRestorative bonds can be classified according to their maturity, which is the date when BioRestorative Therapies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| BIOGEN INC 52 Corp BondUS09062XAD57 | View | |
| BIOGEN INC 405 Corp BondUS09062XAF06 | View | |
| BIOGEN INC Corp BondUS09062XAG88 | View | |
| BIOGEN INC Corp BondUS09062XAH61 | View | |
| BIIB 325 15 FEB 51 Corp BondUS09062XAK90 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
BioRestorative Therapies Predictive Daily Indicators
BioRestorative Therapies intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BioRestorative Therapies stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
BioRestorative Therapies Forecast Models
BioRestorative Therapies' time-series forecasting models are one of many BioRestorative Therapies' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BioRestorative Therapies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About BioRestorative Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how BioRestorative Therapies prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BioRestorative shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as BioRestorative Therapies. By using and applying BioRestorative Stock analysis, traders can create a robust methodology for identifying BioRestorative entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (64.31) | (67.52) | |
| Operating Profit Margin | (93.96) | (98.65) | |
| Net Loss | (64.31) | (67.52) | |
| Gross Profit Margin | (1.54) | (1.47) |
Current BioRestorative Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. BioRestorative analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. BioRestorative analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 13.0 | Buy | 2 | Odds |
Most BioRestorative analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand BioRestorative stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of BioRestorative Therapies, talking to its executives and customers, or listening to BioRestorative conference calls.
BioRestorative Stock Analysis Indicators
BioRestorative Therapies stock analysis indicators help investors evaluate how BioRestorative Therapies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading BioRestorative Therapies shares will generate the highest return on investment. By understating and applying BioRestorative Therapies stock analysis, traders can identify BioRestorative Therapies position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 1.7 M | |
| Common Stock Shares Outstanding | 4.2 M | |
| Total Stockholder Equity | 10 M | |
| Property Plant And Equipment Net | 507.5 K | |
| Cash And Short Term Investments | 11.1 M | |
| Cash | 884.4 K | |
| Accounts Payable | 189.4 K | |
| Net Debt | -722.1 K | |
| 50 Day M A | 1.9553 | |
| Total Current Liabilities | 2.6 M | |
| Other Operating Expenses | 15.4 M | |
| Non Current Assets Total | 1.2 M | |
| Stock Based Compensation | 7.8 M |
Additional Tools for BioRestorative Stock Analysis
When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.